amyloid

(redirected from Familial amyloidotic polyneuropathy)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.

amyloid

[′am·ə‚lȯid]
(pathology)
An abnormal protein deposited in tissues, formed from the infiltration of an unknown substance, probably a carbohydrate.
References in periodicals archive ?
A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP).
Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it will present new data from its ALN-TTR program at the VIIIth International Symposium on Familial Amyloidotic Polyneuropathy being held in Kumamoto, Japan from November 20-22, 2011.
The study enrolled 26 patients and gene carriers with seven different amyloidogenic TTR mutations, the most common being the Val30Met mutation that is the primary cause of familial amyloidotic polyneuropathy (FAP).
Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that The Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) adopted a positive opinion for ALN-TTR01 designation as an orphan medicinal product for the treatment of familial amyloidotic polyneuropathy (FAP), one of the predominant forms of transthyretin (TTR)-mediated amyloidosis (ATTR).

Full browser ?